glp-1 receptor agonists in pediatric and adolescent obesity Glucagon-Like Peptide-1 (GLP-1) | Current Treatment Options in Pediatrics Oral GLP-1-Based Therapeutics in the

Trichotomization: Q1vsQ4) reveals that a high expression of four genes (TDO2, IDO1, IDO2, and Slc7a11) involved in kynurenine synthesis, from tryptophan, and transport is associated with a worse prognosis [256]

Its prevalence varies significantly due to factors such as geographic location, regional differences, ethnicity, dietary habits, and economic conditions

doi:10.1038/scibx.2012.3

Spinal stenosis is a structural narrowing of the spinal canal caused by gradual age-related changes, and the underlying narrowing does not reverse itself

Burks et al[34] has shown that losartan, an inhibitor of the angiotensin II type 1 receptor (AT1), was able to combat disuse atrophy in aged mice that were subjected to hindlimb immobilization, and this protective mechanism was due to an increased activation of the Akt/mTOR pathway